Table 1 Main characteristic of study patients (N = 200)
No. of patients (%) | |
|---|---|
Age at surgery, years | |
Median (range) | 58 (31–84) |
Menopausal status | |
Pre-menopausal | 63 (31.5) |
Post- menopausal | 137 (68.5) |
Tumour size: cm in diameter | |
≤ 2 | 94 (47.0) |
> 2 | 106 (53.0) |
Nodal status | |
Node-negative | 105 (52.5) |
Node-positive | 95 (47.5) |
ER status | |
Poor (<10 % of stained cells) | 42 (21.0) |
Rich (≥10 % of stained cells) | 158 (79.0) |
PgR status | |
Poor (<10 % of stained cells) | 86 (43.0) |
Rich (≥10 % of stained cells) | 114 (57.0) |
Ki-67 | |
Low (<14 % of stained cells) | 91 (45.5) |
High (≥14 % of stained cells) | 109 (54.5) |
HER2 status | |
Negative | 183 (91.5) |
Positive | 17 (8.5) |
Phenotypea | |
Luminal A | 64 (32.0) |
Luminal B (HER2-neg) | 85 (42.5) |
Luminal B (HER2-pos) | 9 (4.5) |
HER2 positive (non luminal) | 8 (4.0) |
Triple negative | 34 (17.0) |
Adjuvant systemic therapyb | |
No | 87 (43.5) |
Yes | 113 (56.5) |